Horizon Therapeutics Publ...

NASDAQ: HZNP · Real-Time Price · USD
116.30
0.00 (0.00%)
At close: Jan 16, 2025, 10:00 PM

Horizon Therapeutics Public Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
2.35B 1.58B
Short-Term Investments
28.23M 26.52M
Long-Term Investments
n/a n/a
Other Long-Term Assets
204.13M 140.74M
Receivables
676.35M 632.77M
Inventory
169.56M 225.73M
Other Current Assets
449.35M 360.94M
Total Current Assets
3.65B 2.8B
Property-Plant & Equipment
340.51M 292.3M
Goodwill & Intangibles
4.49B 4.91B
Total Long-Term Assets
5.46B 5.88B
Total Assets
9.11B 8.68B
Account Payables
155.8M 30.13M
Deferred Revenue
n/a n/a
Short-Term Debt
16M 16M
Other Current Liabilities
777.34M 840.45M
Total Current Liabilities
949.14M 886.57M
Long-Term Debt
2.55B 2.56B
Other Long-Term Liabilities
204.45M 173.08M
Total Long-Term Liabilities
3.09B 3.12B
Total Liabilities
4.04B 4.01B
Total Debt
2.56B 2.57B
Common Stock
23K 23K
Retained Earnings
590.01M 318.61M
Comprehensive Income
12.53M -14.99M
Shareholders Equity
5.07B 4.67B
Total Investments
28.23M 26.52M